Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · IEX Real-Time Price · USD
5.72
-0.26 (-4.35%)
At close: May 7, 2024, 4:00 PM
5.70
-0.02 (-0.35%)
After-hours: May 7, 2024, 7:14 PM EDT
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $244.46 million as of May 8, 2024. Its market cap has increased by 177.16% in one year.
Market Cap
244.46M
Enterprise Value
156.54M
1-Year Change
177.16%
Ranking
Category
Stock Price
$5.72
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $244.46M, a decrease of -44.49%. That is a compound annual growth rate of -17.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2024 | 248.60M | -4.35% |
| May 6, 2024 | 259.90M | -1.48% |
| May 3, 2024 | 263.80M | 1.54% |
| May 2, 2024 | 259.80M | 0.97% |
| May 1, 2024 | 257.30M | -3.52% |
| Apr 30, 2024 | 266.70M | -6.29% |
| Apr 29, 2024 | 284.60M | -1.35% |
| Apr 26, 2024 | 288.50M | 8.70% |
| Apr 25, 2024 | 265.40M | -2.82% |
| Apr 24, 2024 | 273.10M | -0.76% |
| Apr 23, 2024 | 275.20M | 5.72% |
| Apr 22, 2024 | 260.30M | 3.25% |
| Apr 19, 2024 | 252.10M | 0.48% |
| Apr 18, 2024 | 250.90M | 0.52% |
| Apr 17, 2024 | 249.60M | 4.09% |
| Apr 16, 2024 | 239.80M | 2.22% |
| Apr 15, 2024 | 234.60M | 17.07% |
| Apr 12, 2024 | 200.40M | -7.52% |
| Apr 11, 2024 | 216.70M | -4.16% |
| Apr 10, 2024 | 226.10M | -1.09% |
| Apr 9, 2024 | 228.60M | -0.57% |
| Apr 8, 2024 | 229.90M | -9.13% |
| Apr 5, 2024 | 253.00M | -1.33% |
| Apr 4, 2024 | 256.40M | -0.35% |
| Apr 3, 2024 | 257.30M | -0.66% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EDAP TMS | 264.92M |
| Candel Therapeutics | 264.71M |
| FibroBiologics | 262.41M |
| Prelude Therapeutics | 261.60M |
| Quantum-Si incorporated | 260.94M |
| XBiotech | 258.53M |
| Coherus BioSciences | 257.64M |
| Foghorn Therapeutics | 254.97M |